Cibc Private Wealth Group, LLC Lava Therapeutics Nv Transaction History
Cibc Private Wealth Group, LLC
- $51.4 Billion
- Q2 2024
A detailed history of Cibc Private Wealth Group, LLC transactions in Lava Therapeutics Nv stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 6,000 shares of LVTX stock, worth $10,080. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,000
Previous 6,000
-0.0%
Holding current value
$10,080
Previous $19,000
47.37%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding LVTX
# of Institutions
26Shares Held
3.76MCall Options Held
85.8KPut Options Held
36.8K-
Redmile Group, LLC San Francisco, CA2.07MShares$3.48 Million0.24% of portfolio
-
Bruce & Co., Inc. Chicago, IL772KShares$1.3 Million0.68% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L3368KShares$617,5370.1% of portfolio
-
Two Sigma Investments, LP New York, NY112KShares$188,8970.0% of portfolio
-
Alpha Wave Global, LP New York, NY87.4KShares$146,8260.08% of portfolio
About LAVA Therapeutics NV
- Ticker LVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,797,700
- Market Cap $43.3M
- Description
- LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company, through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer...